Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. mGlu3 NAMs as Therapeutics for Chemoresistant Tumors

    ... has been shown to enhance the chemosensitivity of colorectal cancer stem cells to standard cytotoxic chemotherapy (Neuroscience Poster, ... Small Molecule Featured:  0 Priority:  1 Case manager:  ...

    cttc_admin - 01/23/2024 - 4:42pm

  2. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... T cell therapies have emerged as an effective treatment for cancer and potentially other cardiometabolic and autoimmune diseases. However, ... Cellular Therapy Featured:  0 Priority:  0 Case manager:  ...

    cttc_admin - 01/18/2024 - 9:10am

  3. Current Request for Proposals

    ... Cumulus Oncology is developing anti‑cancer therapies for clinical settings in areas of high unmet need, with the ... will be reviewed for the quality of their scientific content, creativity, and potential for impact at scale. Proposals related to ...

    cttc_admin - 12/13/2023 - 4:47pm

  4. Novel Targets Involved in Ferroptosis for Therapeutic Development in Oncology

    ... April 2, 2024 - 12:00am Cumulus Oncology is developing anti‑cancer therapies for clinical settings in areas of high unmet need, with the ...

    cttc_admin - 03/14/2024 - 6:11pm

  5. The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

    ... Amgen, AstraZeneca, Bayer, and Merck will co-fund the whole-genome sequencing (WGS) of 250,000 samples and have access to the resulting ... associations and targets for intervention by analyzing whole-genome sequence data derived from Vanderbilt University Medical Center's ...

    sommers - 07/20/2023 - 10:17am

  6. ThermoFisher Scientific - Research Interest Areas

    ... analysis; fluorescent probes for measuring cell health & content; functional flow cytometry reagents; fluorescent assays run on Qubit ... Cell and Gene Therapy T cell therapy; cancer vaccine; gene delivery system; lentivirus, adeno-associated virus ...

    cttc_admin - 01/30/2024 - 12:26pm

  7. Diagnostics Management Team

    ... Field of Use: Oncology Featured:  0 Priority:  0 Case manager:  ...

    cttc_admin - 01/23/2024 - 1:37pm

  8. Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders

    ... therapeutic to many neurological disorders and well as oncology through the use of dual specific mGlu2/3 Antagonists (LY341495, ... Small Molecule Featured:  0 Priority:  1 Case manager:  ...

    cttc_admin - 01/23/2024 - 4:43pm

  9. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... THER) (“Theralink” or the “Company”) , a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, today announced that it has acquired an exclusive license from ...

    sommers - 04/24/2023 - 1:45pm

  10. Tech Connect, Vol. 6, Issue 22: CTTC team presents, participates at 2016 SEMDA meeting

    ... with a mid-sized pharmaceutical company to discuss anti-cancer compounds developed by Stephen Fesik from the Department of ... working with Vanderbilt and contributing to the educational content and advising within the Innovation Center . ...

    steelmk - 11/10/2016 - 7:45am